Data / Form D filings / Endosee Corp
Endosee Corp: Form D filings
Endosee Corp, a biotechnology company in Los Altos, CA, filed 4 Form D notices with the SEC between 2011 and 2014. The latest, on June 2, 2014, reports $1.8 million sold of a $2.6 million offering to 10 investors.
Find out what Endosee Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4546 El Camino Real, Suite 215, Los Altos, CA, 94022
- Phone
- (650) 397-5174
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1534100
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2014 | Amendment | $2,600,000 | $1,805,083 | $794,917 | 10 | Jan 16, 2014 | sec.gov |
| Jan 31, 2014 | New notice | $1,600,000 | $1,005,083 | $594,917 | 7 | Jan 16, 2014 | sec.gov |
| Feb 6, 2013 | New notice | $2,500,000 | $1,679,982 | $820,018 | 8 | Jun 11, 2012 | sec.gov |
| Nov 10, 2011 | New notice | $1,000,000 | $887,672 | $112,328 | 12 | Oct 31, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Xiaolong (Bruce) OuYang | Executive Officer, Director | |
| Kevin D. Rooney | Executive Officer | |
| Paul D. Indman | Executive Officer, Director | |
| Shih-Ping (Bob) Wang | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Jun 2, 2014 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Endosee Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.